There has been growing criticism of “vaccine inequality” as developing countries struggle to secure supplies while wealthy nations begin inoculating populations.
A lot of people are surviving cancer because new treatments are so effective. But there's one thing that stands in the way for many people, and that's having the money to pay for the drugs to fight their cancer.
Value-based drug pricing helps us to understand the maximum amount of money we're willing to pay for treatments that could benefit patients and save lives.
Americans pay more for prescription drugs than people in most other Western countries.
Macroeconomic pressures have hit the R&D returns of life sciences firms.